JEDDAH, Saudi Arabia – November 30, 2025 – Fosun Health and Fakeeh Care Group have formally entered into a strategic partnership to jointly explore cooperation across four key domains: specialty development and academic exchange, IT and digital hospital solutions, preventive medicine utilizing wearable devices, and stem cell and regenerative medicine. This collaboration injects fresh momentum into China-Saudi healthcare cooperation within the framework of the Belt and Road Initiative and contributes to the advancement of Saudi Arabia’s Vision 2030 in the healthcare sector.

Fosun Health and Saudi Arabia’s Fakeeh Care Group forge a strategic healthcare partnership

The partnership follows a recent visit by a senior Fosun Health delegation to Saudi Arabia for in-depth discussions with Fakeeh Care Group, a leading private healthcare provider in the region. The delegation was led by Mr. Hu Hang, Chairman and Chief Executive Officer of Fosun Health, and included Mr. Shen Yun, Co-President and Chief Strategy Officer of Fosun Health, and Mr. Zhao Xiaodong, Vice President of Fosun Health and Director of Foshan Fosun Chancheng Hospital.

The Fosun Health leadership delegation tours the Fakeeh Care Group flagship hospital in Jeddah

During the visit, the Fosun Health team toured Fakeeh Care Group's flagship hospital in Jeddah. Executives from both sides held extensive discussions on hospital planning, clinical discipline operations, and service quality standards. Mr. Hu Hang expressed his appreciation for Fakeeh Care Group's systematic management, advanced facilities, and high service standards, stating his anticipation for “close collaboration between the teams to ensure the solid implementation of joint projects.” Dr. Sohail Bajammal, Chief Executive Officer of Fakeeh Care Group's Jeddah flagship hospital, noted the vast potential of Saudi Arabia's healthcare market and conveyed his eagerness to “introduce Fosun Health’s experience and innovative models from China to support the successful execution of projects in Saudi Arabia.”

Subsequently, witnessed by Mr. Hu Hang and Dr. Mazen Fakeeh, President of Fakeeh Care Group, a Memorandum of Understanding (MoU) was signed by Dr. Sohail Bajammal, Chief Executive Officer of the Fakeeh Care Group flagship hospital in Jeddah and Mr. Zhao Xiaodong, solidifying the strategic partnership. This agreement formally initiates comprehensive collaboration in the outlined core areas, which aligns closely with the biotechnology localization objectives under Saudi Arabia’s Vision 2030. The partnership aims to enhance healthcare capabilities and foster the adoption of innovative models in the Middle East through multidimensional cooperation in specialty co-development, technological synergy, and research translation.

Signing ceremony marks the strategic partnership between Fosun Health and Fakeeh Care Group

Under the cooperative framework, the two parties will establish regular academic exchange mechanisms in disciplines such as oncology, cardiovascular diseases, and women’s and children’s health. These exchanges will leverage tele-consultation, personnel visits, and thematic workshops to facilitate a two-way sharing of clinical expertise and hospital management experience. On the technological front, Foshan Fosun Chancheng Hospital will contribute its mature smart hospital management system to collaborate with Fakeeh Care Group on digital hospital upgrades and localized implementation. A key focus will be developing smart healthcare solutions tailored to the Gulf Cooperation Council (GCC) market and jointly building an integrated chronic disease management model that combines device monitoring, AI-powered early warning, and insurance coordination. Furthermore, the partners will establish a joint research and translation platform in the field of stem cell and regenerative medicine to support Saudi Arabia’s strategic push for biotechnology localization.

 This visit and the signing of the MoU mark a crucial step in Fosun Health’s international expansion within the Middle East and represent a significant move to deepen strategic synergy with Fakeeh Care Group. Both parties intend to capitalize on their complementary resources to accelerate collaboration in medical technology sharing, joint talent development, and industrial innovation translation, driving the partnership from strategic consensus toward substantive outcomes.

This cross-border healthcare partnership is set to not only provide Saudi citizens with higher quality, more accessible medical services—supporting the advancement of the healthcare pillar within Saudi Arabia's Vision 2030—but also infuse fresh momentum into international medical cooperation under the Belt and Road Initiative. Fosun Health looks forward to working closely and innovatively with Fakeeh Care Group to establish a benchmark model for Sino-Saudi and wider Middle Eastern healthcare collaboration, ensuring that the benefits of cross-border medical synergy reach broader populations.

About Fosun Health

Shanghai Fosun Health Technology (Group) Co., Ltd. (“Fosun Health”), founded in 2010, is a controlling subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Codes: 600196.SH, 02196.HK). After over a decade of development, Fosun Health has built an integrated medical service platform centered in the Greater Bay Area, combining comprehensive and specialized hospitals with online and offline channels. As of June 30, 2025, the group operates 19 medical institutions, including 1 Grade III Class A hospital, 5 Grade III hospitals, and 8 Grade II hospitals, with a total approved capacity of 6,600 beds. It holds 9 internet hospital licenses, encompasses 75 provincial/municipal key specialties, and has 5 hospitals accredited with dual GCP (Good Clinical Practice) certification.

About Fakeeh Care Group

Fakeeh Care Group, formerly known as Dr. Soliman Fakeeh Medical Group, provides primary, secondary, and tertiary healthcare, as well as home healthcare and virtual medical services. The group operates 4 major hospitals with a total of 835 beds and maintains a fully integrated healthcare ecosystem. It has been recognized by Newsweek as Saudi Arabia’s best private hospital for four consecutive years. In 2025, it received 14 Center of Excellence accreditations from the Surgical Review Corporation (SRC), making it the single hospital globally to hold the highest number of such certifications in one facility. These accreditations span multiple advanced surgical fields, including robotic surgery, urology, orthopedics, and spine surgery.